Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.

High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol (1987) 43.61

DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci U S A (1979) 21.22

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A (1987) 18.91

Simian virus 40 deoxyribonucleic acid synthesis: the viral replicon. J Virol (1972) 16.59

Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res (1987) 12.80

High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment. Nucleic Acids Res (1984) 10.40

High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res (1983) 9.94

Efficient infection of monkey cells with DNA of simian virus 40. Proc Natl Acad Sci U S A (1981) 8.66

New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63

Local mutagenesis: a method for generating viral mutants with base substitutions in preselected regions of the viral genome. Proc Natl Acad Sci U S A (1978) 8.36

Temperature-sensitive mutants of simian virus 40: infection of permissive cells. J Virol (1971) 7.95

Deletions covering the putative promoter region of early mRNAs of simian virus 40 do not abolish T-antigen expression. Proc Natl Acad Sci U S A (1980) 7.77

Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol (1989) 6.69

Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J (1991) 6.13

A region of the polyoma virus genome between the replication origin and late protein coding sequences is required in cis for both early gene expression and viral DNA replication. Nucleic Acids Res (1981) 6.11

High mutation frequency in DNA transfected into mammalian cells. Proc Natl Acad Sci U S A (1983) 6.05

In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J Virol (1991) 6.02

Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J Virol (1984) 5.89

Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A (1982) 5.73

Transformation of mouse fibroblasts to methotrexate resistance by a recombinant plasmid expressing a prokaryotic dihydrofolate reductase. Proc Natl Acad Sci U S A (1981) 5.38

A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J Virol (1988) 5.28

DNA infectivity and the induction of host DNA synthesis with temperature-sensitive mutants of simian virus 40. J Virol (1975) 5.22

Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function. J Virol (1984) 4.98

Territorial limits and functional anatomy of the simian virus 40 replication origin. Proc Natl Acad Sci U S A (1982) 4.77

Genetic analysis of simian virus 40. 3. Characterization of a temperature-sensitive mutant blocked at an early stage of productive infection in monkey cells. J Virol (1972) 4.76

A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol (1987) 4.57

Bovine papilloma virus contains an activator of gene expression at the distal end of the early transcription unit. Mol Cell Biol (1983) 4.56

Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci U S A (1988) 4.41

Mutational analysis of the simian virus 40 replicon: pseudorevertants of mutants with a defective replication origin. Proc Natl Acad Sci U S A (1979) 4.15

Somatic cells efficiently join unrelated DNA segments end-to-end. Mol Cell Biol (1982) 4.13

Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A (1984) 3.92

Viable deletion mutants of simian virus 40: selective isolation by means of a restriction endonuclease from Hemophilus parainfluenzae. Proc Natl Acad Sci U S A (1974) 3.71

Mutational analysis of simian virus 40 T antigen: isolation and characterization of mutants with deletions in the T-antigen gene. Mol Cell Biol (1983) 3.67

Positive and negative autoregulation of the adeno-associated virus type 2 genome. J Virol (1986) 3.67

Transfected DNA is mutated in monkey, mouse, and human cells. Mol Cell Biol (1984) 3.63

c-fos sequence necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate and the calcium ionophore. Mol Cell Biol (1987) 3.52

Topological requirements for homologous recombination among DNA molecules transfected into mammalian cells. Mol Cell Biol (1985) 3.45

Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J Virol (1987) 3.44

Functional organization of the simian virus 40 origin of DNA replication. Mol Cell Biol (1986) 3.40

Transformation of mammalian cells with an amplifiable dominant-acting gene. Proc Natl Acad Sci U S A (1980) 3.39

FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J (1991) 3.19

Regulated gene expression in transfected primary chicken erythrocytes. Proc Natl Acad Sci U S A (1986) 3.17

Cis-acting sequences responsible for the transcriptional activation of human T-cell leukemia virus type I constitute a conditional enhancer. Proc Natl Acad Sci U S A (1986) 3.12

Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation. Proc Natl Acad Sci U S A (1982) 3.12

Mutations of the Rous sarcoma virus env gene that affect the transport and subcellular location of the glycoprotein products. J Cell Biol (1984) 3.11

Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol (1990) 3.09

Biochemical activities of T-antigen proteins encoded by simian virus 40 A gene deletion mutants. Mol Cell Biol (1983) 3.06

Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Res (2001) 3.06

Expression of recombinant genes containing herpes simplex virus delayed-early and immediate-early regulatory regions and trans activation by herpesvirus infection. J Virol (1984) 3.00

High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion. Mol Cell Biol (1981) 2.97

Autoregulation of the human cytomegalovirus major immediate-early gene. J Virol (1985) 2.91

Polyomavirus origin for DNA replication comprises multiple genetic elements. J Virol (1983) 2.89

How damaged is the biologically active subpopulation of transfected DNA? Mol Cell Biol (1984) 2.88

New host cell system for regulated simian virus 40 DNA replication. Mol Cell Biol (1985) 2.82

Mutagenesis of a shuttle vector plasmid in mammalian cells. Mol Cell Biol (1984) 2.77

Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing. J Virol (1988) 2.74

Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription. J Virol (1989) 2.69

Assembly of transfected DNA into chromatin: structural changes in the origin-promoter-enhancer region upon replication. EMBO J (1984) 2.69

Mutations in the cytoplasmic domain of the influenza virus hemagglutinin affect different stages of intracellular transport. J Cell Biol (1985) 2.60

Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J Virol (1989) 2.53

A domain of SV40 capsid polypeptide VP1 that specifies migration into the cell nucleus. EMBO J (1986) 2.51

Electric field-mediated DNA transfer: transient and stable gene expression in human and mouse lymphoid cells. Mol Cell Biol (1986) 2.51

Short-term, high-efficiency expression of transfected DNA. Mol Cell Biol (1984) 2.47

Human cytomegalovirus DNA. I. Molecular weight and infectivity. J Virol (1978) 2.43

Sequence specificity of point mutations induced during passage of a UV-irradiated shuttle vector plasmid in monkey cells. Mol Cell Biol (1986) 2.40

Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. Proc Natl Acad Sci U S A (1991) 2.38

Simian virus 40 recombinants are produced at high frequency during infection with genetically mixed oligomeric DNA. Proc Natl Acad Sci U S A (1979) 2.38

A human parvovirus, adeno-associated virus, as a eucaryotic vector: transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. Mol Cell Biol (1984) 2.36

DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy. J Clin Oncol (2011) 2.34

A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol (1992) 2.34

Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J Virol (1986) 2.33

Sequences at the capped 5'-ends of polyoma virus late region mRNAs: an example of extreme terminal heterogeneity. Nucleic Acids Res (1981) 2.32

Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome. Proc Natl Acad Sci U S A (1984) 2.32

Establishment of a transient expression system for Dictyostelium discoideum. Nucleic Acids Res (1988) 2.30

Specificity of mutations induced in transfected DNA by mammalian cells. EMBO J (1984) 2.27

The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration. J Virol (1989) 2.27

Cloning and expression of human lecithin-cholesterol acyltransferase cDNA. Proc Natl Acad Sci U S A (1986) 2.27

Minichromosome assembly of non-integrated plasmid DNA transfected into mammalian cells. Nucleic Acids Res (1985) 2.20

Indiscriminate recombination in simian virus 40-infected monkey cells. Proc Natl Acad Sci U S A (1980) 2.18

The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity. EMBO J (1992) 2.16

Simian virus 40 late transcripts lacking excisable intervening sequences are defective in both stability in the nucleus and transport to the cytoplasm. J Virol (1989) 2.10

Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals. Proc Natl Acad Sci U S A (1988) 2.10

Polyoma mutants that productively infect F9 embryonal carcinoma cells do not rescue wild-type polyoma in F9 cells. Proc Natl Acad Sci U S A (1982) 2.09

Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. J Virol (1992) 2.09

Promoter domains required for expression of plasmid-borne copies of the herpes simplex virus thymidine kinase gene in virus-infected mouse fibroblasts and microinjected frog oocytes. Mol Cell Biol (1985) 2.09

Mutational analysis of the envelope gene of Moloney murine leukemia virus. J Virol (1993) 2.08

Enhanced transformation by a simian virus 40 recombinant virus containing a Harvey murine sarcoma virus long terminal repeat. Mol Cell Biol (1983) 2.08

AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation. Mol Cell Biol (1995) 2.03

Construction and functional characterization of polyomavirus genomes that separately encode the three early proteins. J Virol (1984) 2.02

Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells. Nucleic Acids Res (1982) 2.01

Tpl-2 acts in concert with Ras and Raf-1 to activate mitogen-activated protein kinase. Proc Natl Acad Sci U S A (1994) 2.00

Intramolecular recombination between transfected repeated sequences in mammalian cells is nonconservative. Mol Cell Biol (1986) 1.99

Electroporation by using bipolar oscillating electric field: an improved method for DNA transfection of NIH 3T3 cells. Proc Natl Acad Sci U S A (1991) 1.98

Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor. J Virol (1989) 1.96

Gene transfer: DNA microinjection compared with DNA transfection with a very high efficiency. Mol Cell Biol (1982) 1.94

Reverse transcription of retroviral genomes: mutations in the terminal repeat sequences. J Virol (1985) 1.90

Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing. Mol Cell Biol (1991) 1.90

Viable deletion mutants in the simian virus 40 early region. Proc Natl Acad Sci U S A (1978) 1.89

Site of host restriction of simian virus 40 mutants in an established African green monkey kidney cell line. J Virol (1969) 1.86

Properties of the simian virus 40 (SV40) large T antigens encoded by SV40 mutants with deletions in gene A. J Virol (1986) 1.86

Detection of Epstein-Barr viral genome in nonproductive cells. Nat New Biol (1971) 7.91

Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature (1973) 6.68

Structural polypeptides of simian virus 40. J Virol (1971) 4.83

Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nat New Biol (1972) 4.66

Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med (1984) 4.47

Human cytomegalovirus. I. Purification and characterization of viral DNA. J Virol (1973) 4.43

Analysis of simian virus 40 DNA with the restriction enzyme of Haemophilus aegyptius, endonuclease Z. J Virol (1973) 3.98

Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 3.82

Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. J Virol (1967) 2.95

Replication of Epstein-Barr virus in human epithelial cells infected in vitro. Nature (1984) 2.81

IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol Cell Biol (1997) 2.70

EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J Virol (1991) 2.70

Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication. J Virol (1980) 2.69

Reassociation kinetics for Epstein-Barr virus DNA: nonhomology to mammalian DNA and homology of viral DNA in various diseases. J Virol (1973) 2.57

Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54

Detection of human cytomegalovirus and analysis of strain variation. Yale J Biol Med (1976) 2.53

Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine. J Virol (1987) 2.33

Infectious poliovirus RNA: a sensitive method of assay. Virology (1965) 2.28

Enhancement of infectivity of poliovirus RNA with diethylaminoethyl-dextran (DEAE-D). Arch Gesamte Virusforsch (1965) 2.25

Acyclovir inhibition of Epstein-Barr virus replication. Proc Natl Acad Sci U S A (1980) 2.23

Structure and function of the polypeptides in simian virus 40. I. Existence of subviral deoxynucleoprotein complexes. J Virol (1972) 2.16

DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc Natl Acad Sci U S A (1973) 2.02

Human cytomegalovirus. II. Lack of relatedness to DNA of herpes simples I and II, Epstein-Barr virus, and nonhuman strains of cytomegalovirus. J Virol (1974) 1.99

Prolonged inhibitory effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against replication of Epstein-Barr virus. J Virol (1984) 1.88

Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1. J Virol (1976) 1.87

IRF7: activation, regulation, modification and function. Genes Immun (2011) 1.80

Effect of 12-O-tetradecanoyl-phorbol-13-acetate on the replication of Epstein-Barr virus. I. Characterization of viral DNA. Virology (1979) 1.80

The uptake of SV40 DNA by nonpermissive cells in the presence of DEAE-dextran. Biochim Biophys Acta (1971) 1.76

The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1. Proc Natl Acad Sci U S A (1998) 1.75

Absence of Epstein-Barr viral DNA in Amercian Burkitt's lymphoma. N Engl J Med (1973) 1.72

Cytotoxicity of sesquiterpene lactones. Cancer Res (1971) 1.71

Replication of viral deoxyribonucleic acid and breakdown of cellular deoxyribonucleic acid in Epstein-Barr virus infection. J Virol (1972) 1.70

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci U S A (2001) 1.63

A microtiter plate technique for the agglutination typing of Diplococcus pneumoniae. J Infect Dis (1970) 1.62

A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet (1986) 1.61

Replication of EBV in epithelial cells during infectious mononucleosis. Nature (1977) 1.61

Induction of Epstein-Barr virus-associated DNA polymerase by 12-O-tetradecanoylphorbol-13-acetate. Purification and characterization. J Biol Chem (1980) 1.57

Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol (1983) 1.57

Structural proteins of simian virus 40. I. Histone characteristics of low-molecular-weight polypeptides. J Virol (1975) 1.56

Oral poliovirus vaccination in newborn African infants. The inhibitory effect of breast feeding. Am J Dis Child (1966) 1.56

Novel acyclic adenosine analogs inhibit Epstein-Barr virus replication. Antimicrob Agents Chemother (1987) 1.55

Epstein-Barr virus DNA synthesized in superinfected Raji cells. Virology (1977) 1.55

Epstein-Barr virus polypeptides: effect of inhibition of viral DNA replication on their synthesis. J Virol (1981) 1.48

Autologous human B and T lymphoblastoid cell lines. Nature (1974) 1.48

Structure and function of the polypeptides in simian virus 40. II. Transcription of subviral deoxynucleoprotein complexes in vitro. J Virol (1972) 1.47

Epstein-Barr virus: culprit or consort? N Engl J Med (1992) 1.46

Cellular basis for susceptibility to mouse cytomegalovirus: evidence from tracheal organ culture. J Gen Virol (1979) 1.46

Phosphorylation of acyclovir [9-(2-hydroxyethoxymethyl)guanine] in Epstein-Barr virus-infected lymphoblastoid cell lines. J Virol (1981) 1.44

Polypeptide synthesis and phosphorylation in Epstein-Barr virus-infected cells. J Virol (1980) 1.43

Biologic activity of isolated viral nucleic acids. Prog Med Virol (1970) 1.40

Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole. J Virol (1999) 1.39

Epstein-Barr virus-associated thymidine kinase. J Virol (1978) 1.38

Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J Virol (1999) 1.33

Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1. J Virol (2000) 1.31

Antisera to human cytomegaloviruses prepared in the guinea pig: specific immunofluorescence and complement fixation tests. J Immunol (1974) 1.31

Regulation of the Epstein-Barr virus DNA polymerase gene. J Virol (1992) 1.31

Sites of replication of chromosomal DNA in a eukaryotic cell. Proc Natl Acad Sci U S A (1972) 1.29

Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. J Virol (1996) 1.27

RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism. J Virol (1994) 1.27

Papovaviridae. Intervirology (1974) 1.26

Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx. N Engl J Med (1976) 1.26

Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses. Am J Med (1982) 1.25

Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7. J Virol (2001) 1.23

Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency. J Virol (1999) 1.23

Epstein-Barr Virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br J Cancer (2011) 1.22

Diseases and mechanisms of persistent DNA virus infection: latency and cellular transformation. J Infect Dis (1975) 1.22

Detection of autonomous replicating sequences (ars) in the genome of Epstein-Barr virus. Proc Natl Acad Sci U S A (1983) 1.22

Qualitative and quantitative analyses of Epstein-Barr virus early antigen diffuse component by western blotting enzyme-linked immunosorbent assay with a monoclonal antibody. J Virol (1985) 1.20

Dissociation of opsonized particle phagocytosis and respiratory burst activity in an Epstein-Barr virus-infected myeloid cell line. J Cell Biol (1980) 1.19

Identification and functional characterization of Epstein-Barr virus DNA polymerase by in vitro transcription-translation of a cloned gene. J Virol (1991) 1.18

Epstein-Barr virus: inhibition of replication by three new drugs. Science (1983) 1.17

Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1. J Virol (2001) 1.16

Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon. Antimicrob Agents Chemother (1991) 1.15

Simultaneous infection with multiple herpesviruses. Am J Med (1979) 1.15

Unconventional processing of the 3' termini of the Epstein-Barr virus DNA polymerase mRNA. Proc Natl Acad Sci U S A (1993) 1.14

Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol Cell Biol (1994) 1.14

Infections with cytomegalovirus in bone marrow transplantation: report of a workshop. J Infect Dis (1975) 1.13

Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR. Virology (1989) 1.11

The Epstein-Barr virus immediate-early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle. J Virol (1998) 1.11

Expression and localization of the Epstein-Barr virus-encoded protein kinase. J Virol (2004) 1.11

Induction of DNA polymerase activity after superinfection of Raji cells with Epstein-Barr virus. Virology (1980) 1.10

Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res (2000) 1.09

Effects of 12-O-tetradecanoyl-phorbol-13-acetate on cell proliferation and Epstein-Barr virus DNA replication. Virology (1982) 1.08

Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency. Mol Cell Biol (1999) 1.08

Plasmid origin of replication of herpesvirus papio: DNA sequence and enhancer function. J Virol (1990) 1.08

Epstein-Barr virus polypeptides: identification of early proteins and their synthesis and glycosylation. J Virol (1981) 1.08

Comparative efficacy and selectivity of some nucleoside analogs against Epstein-Barr virus. Antimicrob Agents Chemother (1985) 1.07

Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection. Proc Natl Acad Sci U S A (1993) 1.07

The Epstein-Barr virus (EBV) SM protein enhances pre-mRNA processing of the EBV DNA polymerase transcript. J Virol (1998) 1.06

Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy. J Infect Dis (1994) 1.04

Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator. Clin Exp Metastasis (1999) 1.03

Phosphorylation of acyclovir in vitro in activated Burkitt somatic cell hybrids. Antimicrob Agents Chemother (1983) 1.03

Zidovudine-resistant human immunodeficiency virus type 1 genomes detected in plasma distinct from viral genomes in peripheral blood mononuclear cells. J Infect Dis (1993) 1.03

A noncanonical poly(A) signal, UAUAAA, and flanking elements in Epstein-Barr virus DNA polymerase mRNA function in cleavage and polyadenylation assays. Virology (1997) 1.03

Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine. Antimicrob Agents Chemother (1989) 1.02

Acyclovir and Epstein-Barr virus infection. J Antimicrob Chemother (1983) 1.00

The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. Cancer Res (1998) 0.98

Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration. Oncogene (2009) 0.98

Iodination of herpesvirus nucleic acids. J Virol (1975) 0.97